Bright sparks: could bioelectricity make us smarter and healthier? | Medical research

I was again at the checkpoint. The targeted visitors moved as usual. Bored-wanting troopers waved through civilians on foot, dusty cars and rickety vans comprehensive of livestock and produce.

Then the Humvee in front of the gate blew up. Out of the eye-searing blast, I built out the determine of a person running at me, full-speed. He was wearing an explosive vest. I shot him.

A flash of movement to my remaining uncovered a sniper who had just started to raise his gun. I obtained him, way too. Now a mass of persons – possibly 7 – breached the checkpoint. Bang-bang-bang.

There weren’t any additional just after that, only the silent whistle of the desert wind. The lights arrived up and the tech walked in.

“How several did I get?” I requested, as I surrendered my rifle and headgear, chopping off the move of electric power that had been coursing by way of my brain.

She shrugged. “All of them.”

I was in a grey business park in Southern California, nowhere in the vicinity of any checkpoint in any conflict. In my hands was an M4 near-combat rifle modified to fire harmless cartridges. The men and women I was firing at experienced been dreamed up by the programmers of a wall-sized military-training simulation. What was serious was the electrical stimulation gadget on my head. I experienced signed up to have a couple of milliamps from a 9V battery despatched by way of my cranium to take a look at if it would make me a far better shot.

The scientists’ speculation was that the electrical latest would recalibrate a various sort of electricity in my mind: the in a natural way occurring bioelectric alerts that the nervous program depends on to talk. By overpowering these sensitive normal streams with an artificial shock to the govt component of my brain, they hoped to wrench my brain into a condition of alertness and concentration – sufficient to flip this desk-slumping journalist into a fight-ready assassin.

I was obsessed from the second I 1st caught wind of this army brain-stimulation experiment. I had seen this procedure – regarded as transcranial immediate present-day stimulation (tDCS) – bubbling about the science push for a couple years. Among other intriguing results, it appeared to improve almost everything from treatment-resistant depression to bad maths expertise.

This movement of electrical energy, in accordance to the experts who wired me up, might alter the power of connections involving the neurons in my mind, producing them far more likely to fireplace in concert. That pure synchronisation is the foundation of all mastering and rushing it up with an electrical field would theoretically accelerate the rate at which I could find out a new skill.

When I caught my to start with glimpse of this odd new use for electrical energy in 2009, it was the stuff of obscure health-related trials and magic formula armed service assignments. Now, the idea of carrying an electrical stimulator on your head is surely the kind of point you can visualize a person in Silicon Valley executing for a minor more mental edge, alongside intermittent fasting or microdosing psilocybin.

But it’s not just about boosting your brainpower with a volt jolt – there are lots of other means electrical energy is getting used to treat the conditions of system and head. Consider deep-mind stimulation, a remedy of past vacation resort for Parkinson’s disease, in which two electrodes the size and shape of a strand of spaghetti are slid into the deepest pieces of your mind to quieten the disease’s harmful indications.

In the wake of its great results, experts are testing the treatment method on epilepsy, anxiety, obsessive-compulsive problem and being overweight. Then there’s the rise of “electroceuticals”: these rice-grain-sized electrical implants, clamped all over nerves in the overall body, supposedly interrupt their signals and, in rat and pig trials, appeared to reverse diabetic issues, hypertension and asthma.

In 2016, outstanding early effects in human trials, in which they appeared to reverse rheumatoid arthritis, confident Google’s mother or father company, Alphabet, to group up with a pharmaceutical multinational on a £540m enterprise to faucet into the body’s electrical alerts, to check out to handle disorders these types of as Crohn’s and diabetic issues.

So when I noticed the option to be a guinea pig in a US Division of Protection task, of course I jumped at it, and I wasn’t let down: my very own expertise with tDCS was transformative. Receiving my neurons slapped all over by an electric powered subject right away sharpened my capability to focus and, by the transitive property, my sharpshooting skills.

It also felt outstanding – like someone experienced ultimately strike the off swap on all the distracting unfavorable self-chat that experienced, until that instant, been the major service provider of my mind’s elevator new music. I experienced a inclination to get distracted from jobs by my own self-recriminations this consistent qualifications chatter was these a ubiquitous feature of my mind that I had stopped noticing it, but it certainly acquired in the way of tense responsibilities – which include these taking pictures drills. My to start with flavor of energy felt as if another person experienced popped a bell jar over all people internal voices. Their sudden silence built me aware of the electricity they’d had.

When my story detailing the working experience was revealed in New Scientist, it went viral. It was tapping into a little something zeitgeisty. Considering that the early 2000s, hundreds of experiments had pointed to tDCS as a way to enhance the head. The information and the headlines experienced been accumulating for years, but my gonzo knowledge took it out of dry, clinical stuff.

Looking at greenback indicators in the mixture of intriguing lab final results and escalating community fascination, enterprising start-ups promptly began to hawk their personal professional variations of the brain-maximizing headgear I experienced highway-tested. These adorable wearables, which would set you again a handful of hundred bucks, had little in popular with the £10,000 equipment in the Division of Defense’s arsenal.

Nonetheless, they had been before long adopted by people today hunting for any bit of added psychological edge, such as substantial-degree athletes. Right before each individual match, the Golden State Warriors – a group so unbeatable they have been accused of “ruining basketball” – wore them in apply periods to zap their brains into the zone. The US Olympic ski crew utilised headsets in instruction drills, increasing accusations of “brain doping”.

And then arrived the unavoidable backlash. Sceptics begun to wonder if this was all a bit also good to be true. Shortly a wave of studies started to debunk the past glut of hopeful conclusions: a person group electrically stimulated a cadaver and concluded that it was pseudoscientific bullshit a meta-analysis adopted – and concluded that if you averaged out all the effects, you’d close up with very little.

But if electrical medicine was quackery, why did it still appear to be to do the job throughout this sort of a vast swathe of ailments? I could not get the dilemma out of my process: what was the connection between electric power and biology? If this technological know-how labored, I experienced no idea how. So I made a decision to work it out. I have invested the last 10 yrs of my daily life getting electrified by these queries and their responses.

A pure electric recent courses by way of all living points, underpinning their each go and intention. It predates nervous devices and even humanity by itself it animated the bodies of our ancestors prolonged just before the 1st fishy mutants even squelched on to dry land. It is the most historic detail about us. It is among the the most historical things about lifestyle alone. We are fundamentally electrical creatures, but the full extent of our electrification would shock you. This is not the electricity that comes from a battery or the form that turns on the lights and powers the dishwasher. That type of electric power is built of electrons, which are
negatively charged particles flowing in a present.

The human system runs on a very various variation: bioelectricity. As an alternative of electrons, these currents are designed by the actions of generally positively charged ions, this kind of as potassium, sodium and calcium.

Each individual a person of the 40 trillion cells in your body is its personal minor battery with its very own small voltage. When a nerve impulse will come roaring down a nerve fibre, channels open in the neuron and millions of ions get quickly sucked by means of them, getting all their demand with them. The electrical field produced by this mass migration of charge is effective out to about 1m volts for every metre, which at that scale would feel like passing an overall bolt of lightning from one particular of your outstretched hands to the other.

Which is what it feels like to be just about every neuron in your system. This is how all signals travel within just the mind and involving it and each individual organ in the system by means of the anxious process. It’s essential to our ability to assume and communicate and walk and why our knee hurts after a fall, and why the scraped skin heals. It’s what can make gummy bears style sour. It is how we realized we were being thirsty.

But bioelectricity is not confined to the nervous procedure. About the past couple of decades it has come to be very clear that these signals are pressed into company by each and every mobile in your physique, not just those people that govern your perception and motion. Each and every of your skin cells has its individual voltage, which it brings together with neighbouring cells to create an electrical industry. That tingling when you bite your tongue or the inside of your cheek? It’s the wound latest, contacting to the bordering tissue to send out help. Equally, the cells in your bones are electric. Your tooth are electric powered. Your organs are electric – and so is the coat of epithelial tissue that hugs each individual one. Blood cells, much too.

Recently it has been learned that electrical alerts also send out beacons as we increase in the womb to guide us into the eventual shape we will choose. And what it offers us at beginning, it can choose absent to lead to our dying: most cancers cells have their have strange voltage, and modern proof signifies that it marks a sharp departure from the form that healthy cells use to kind the co-working modern society of the entire body. Disrupting these errant signals could continue to keep most cancers cells from metastasising.

Nor is this purely natural electrical energy confined to us animals – the exact indicators have been detected in every little thing from algae to E coli, from fungi to micro organism. Every single residing point is pretty much electric. When our cellular battery runs out, we all die. So what if we figured out how to control the swap?

If you still just can’t rather get your head all-around this, you are not alone. The complete heritage of bioelectricity has been marked – and in some means defined – by the scepticism levelled at the researchers from equally the physics and biology institution.

Even now, many biologists probably really don’t know the whole tale of bioelectricity. In 1995, when Mustafa Djamgoz, a most cancers researcher at Imperial College London, to start with proposed his idea that electrical indicators had been included in cancer, his colleagues overtly dismissed his tips. Nevertheless most cancers bioelectricity it now the subject matter of increasing international focus, Djamgoz still finds himself re-conveying his investigate.

This demonstrates a set of calcified notions embedded in the framework of science: biologists stick to biology, leaving the research of electricity to the physicists and engineers. They just do not converse the identical language. “If you significant in biology, you get possibly 50 {bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} a semester of physics, if that,” claims physicist and biologist Richard Nuccitelli. “You do not even touch electrical engineering.”

This tacit assumption that every industry should really “stay in their lane” has been putting constraints equally on biology and scientific development for a long time. What we have to have is a new framework to carry the body’s unique electrical parameters under one particular roof and analyze them coherently, together.

Contact it the “electrome”. The identification of the genome and microbiome proved critical measures to understanding the comprehensive complexity of biology, but some researchers assume it is now time to plot the outlines of the electrome: the electrical dimensions and houses of cells, the tissues they collaborate to variety, and the electrical forces that are turning out to be concerned in each component of lifestyle.

Just as decoding the genome led us to the principles by which data like eye color is encoded in our DNA, bioelectricity researchers forecast that decoding the electrome will aid us to decipher our body’s multilayered communications devices and give us a way to handle them. Scientists are on the lookout for exact methods to flip the circuits inside our cells that are dependable for almost everything from healing to regeneration to memory.

Restoring cancer cells’ electrical signatures to their healthier point out has reversed tumours in tadpole experiments. Other investigations indicate that sure patterns of electrical action in the mind variety unique sensory experiences, and that these may possibly be recorded and overwritten – increasing the probability of advanced prosthetics that
a person can really feel as thoroughly as they can experience the skin they were born with.

If we are actually electric powered, then we need to all be programmable at the degree of the mobile. But what will materialize when we start to use our knowledge of the electrome to get greater grades in its place of handle most cancers? The gene-editing technology Crispr ushered in a flurry of anxieties about designer infants, and our potential to edit the bioelectric code could elevate very similar fears. In just one analyze, a simple tweak to the electrome brought about practical eyes to increase on a frog’s butt, and in another prompted a worm to mature two heads.

There is a apparent romantic relationship in between our electrome and the condition our bodies choose – from frogs to worms to human beings – so we will need to do considerably far more exploration in advance of another person figures out how to mature them selves a 3rd eye as a social media stunt. Much more worryingly, bioelectricity analysis could all also quickly be misappropriated by that vague but undeniable urge to see humans as occupiers of inferior bodies that could only be enhanced by the addition and substitution of components and software.

So what constraints should we area on upgrading or altering humans? Who will govern the principles on remapping the body’s electrical wiring? What if each individual country’s department of defence put their troopers through the same training I had done in California?

If we are going to check out to manipulate the human body, the least we can do is manipulate it on its own conditions – terms that ended up honed by hundreds of thousands of a long time of evolution. A glut of new observational resources has introduced us to a new understanding of bioelectricity. “With bioelectricity, we are now at the issue the place astronomy was when Galileo invented the telescope,” states Djamgoz.

The 19th century was often referred to as the “electric century” the 21st century could be bioelectric.

We Are Electric: The New Science of Our Body’s Electrome by Sally Adee is released by Canongate (£20). Sally Adee will be speaking at Hay festival on 1 June

DHR can help Texas become a national leader for Hispanic Medical Research

BROWNSVILLE, Texas – DHR Health can play a key job in aiding Texas become a countrywide chief in Hispanic professional medical research.

This was the message the group’s CEO, Dr. Manish Singh, needed to get throughout to a delegation of point out lawmakers that visited DHR Health and fitness-Brownsville recently. 

The lawmakers had been touring the healthcare facility, which is slated to open in March, as part of the RGV Partnership’s 2023 Valley Legislative Tour.

“We have a chance to make a transformational improve in the state of health care in Texas, to come to be a nationwide leader in chopping edge, medical trials of Hispanics,” Singh advised the Rio Grande Guardian Global Information Company, just prior to building his presentation to condition lawmakers.

Singh said legislators need to have to spend attention to the transforming demographics of Texas. The Hispanic inhabitants is developing quickly and a higher share of the state’s workforce will be Hispanic in the not much too distant long run. 

“Our legislators require to pay back focus. If we want to retain the financial engine below of Texas, they need to pay out consideration to this populace,” Singh mentioned.

“But here’s the difficulty. Hispanics have increased costs of heart disorder, diabetes, superior cholesterol, kidney ailments, incredibly early in existence. If these health conditions get to them, they grow to be sick early and quite quickly. My individuals, with these illnesses, I’ve viewed them they go pretty down pretty fast. So, there is a menace to this state’s efficiency, to the financial motor of the upcoming.”

The greatest way to treat these disorders is to get into good professional medical investigate, Singh instructed the Guardian.

“But, guess what? Only 6.5{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the clinical investigate is staying performed on Hispanics nationwide, even nevertheless we are 19 to 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the inhabitants. That is pathetic.”

To do fantastic clinical investigate, Singh mentioned, three factors are needed: folks, put and sources. 

“Place? The Rio Grande Valley has a 95{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} Hispanic inhabitants. People? The DHR Overall health Institute of Research and Enhancement is performing wonderful analysis. We have the right people and the appropriate researchers below. All we will need are means. 

Singh explained DHR Health and fitness is wanting for a just one-time expense in a point out-of-the-artwork exploration facility that specializes on Hispanic wellness. The 35,000 sq. foot facility would have a Phases I – IV medical trials unit, an infusion center, a biobank, a investigation laboratory, upcoming-gen sequencing, a exploration pharmacy, investigate radiologic providers, and a study education middle. 

In his presentation to the condition lawmakers, Singh stated only $4.9 billion of undertaking cash funding for Hispanic health and fitness research is coming to Texas, as in contrast to $79 billion for California, $41 billon for Massachusetts, and $18 billion for New York. 

“You believe they’re greater than us. I never believe so,” Singh mentioned.

The investment requirements to be made in South Texas because it has a predominantly Hispanic inhabitants, Singh mentioned.

“We want to be in the forefront on this,” Singh mentioned. “That’s our desire. That’s the desire of DHR Overall health. We want a one-time transformational investment decision for the future of Texas. As a clinician, I have been in this article for 11 a long time. It is not a little something individuals in the Valley will need. It’s not one thing persons in the Valley want. It is a little something persons in the Valley deserve.”

Editor’s Observe: Right here is a online video recording of the speech Dr. Singh gave to state lawmakers at DHR Wellness-Brownsville:

Movie

https://www.youtube.com/look at?v=oxRi3D0_l4w

Below are some pics from the function:

&#13
&#13
&#13


Top quality journalism requires time, energy and…. Cash!

Manufacturing high quality journalism is not inexpensive. The coronavirus has resulted in falling revenues throughout the newsrooms of the United States. On the other hand, The Rio Grande Guardian International News Service is fully commited to creating quality information reporting on the challenges that make a difference to border residents. The help of our users is vital in ensuring our mission receives fulfilled. 

Can we rely on your assist? If so, click Listed here. Thank you!


Preserve on top rated of the large tales influencing the Texas-Mexico. Be a part of our mailing checklist to acquire regular electronic mail alerts.

Lazarus Group targets medical research and energy

Lazarus Group targets medical research and energy

Scientists at WithSecure have uncovered a cyberattack marketing campaign linked back again to North Korea’s notorious Lazarus Team.

It is particularly uncommon to be capable to website link a marketing campaign so strongly to a perpetrator as WithSecure has been capable to do in this article. The Hackers have been concentrating on healthcare investigate and electricity companies with the intent to dedicate espionage.

Targets incorporate a healthcare investigation business, a maker of engineering applied in the strength, investigation, defense, and healthcare sectors, as nicely as the chemical engineering division of a foremost analysis university.

There are quite a few fascinating factors to this marketing campaign in contrast to previous Lazarus exercise. These incorporate the use of new infrastructure, with the sole reliance on IP addresses without the need of domain names (in a departure from previous assaults).

There’s also a modified version of the Dtrack data stealing malware employed by Lazarus Group and Kimsuky — another team linked with North Korea — in preceding assaults, together with a new edition of GREASE — malware that makes it possible for attackers to develop new administrator accounts with distant desktop protocol privileges that bypasses firewalls.

“While this was initially suspected to be an tried BianLian ransomware assault, the evidence we gathered quickly pointed in a different course. And as we collected additional proof we grew to become much more assured that the attack was executed by a team related to the North Korean federal government, sooner or later major us to confidently conclude it was the Lazarus Group,” claims WithSecure’s senior menace intelligence researcher Sami Ruohonen.

The attack was identified partly owing to an mistake the place the attackers briefly manufactured use of 1 of considerably less than a thousand IP addresses belonging to North Korea.

But WithSecure’s head of threat intelligence Tim West claims this is no bring about for complacency, “In spite of the opsec fails, the actor shown excellent tradecraft and even now managed to complete viewed as steps on meticulously selected endpoints. Even with precise endpoint detection technologies, organizations will need to continuously consider how they react to alerts, and also combine concentrated threat intelligence with regular hunts to present superior defense in depth, specifically in opposition to able and adept adversaries.”

The full report is available on the WithSecure internet site.

Picture credit history: tang90246/depositphotos.com

Tumor organoid biobank-new platform for medical research

  • Pan, W. et al. The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs. Front. Immunol. 13, 982486. https://doi.org/10.3389/fimmu.2022.982486 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Wang, X. et al. Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer. Front. Genet. 13, 943378. https://doi.org/10.3389/fgene.2022.943378 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Sweed, D. et al. The clinicopathological and prognostic factors of hepatocellular carcinoma: A 10-year tertiary center experience in Egypt. World J. Surg. Oncol. 20, 298. https://doi.org/10.1186/s12957-022-02764-2 (2022).

    Article 

    Google Scholar
     

  • Cheng, C., Feng, X., Li, X. & Wu, M. Robust analysis of cancer heterogeneity for high-dimensional data. Stat. Med. 41, 5448–5462. https://doi.org/10.1002/sim.9578 (2022).

    Article 

    Google Scholar
     

  • Abdelraouf, E. M. et al. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Life Sci. 308, 120967. https://doi.org/10.1016/j.lfs.2022.120967 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Elbadawy, M. et al. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids. Biomed. Pharmacother. 142, 112043. https://doi.org/10.1016/j.biopha.2021.112043 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Elbadawy, M. et al. Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biol. Ther. 22, 357–371. https://doi.org/10.1080/15384047.2021.1919004 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338. https://doi.org/10.1016/j.cell.2014.12.021 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597. https://doi.org/10.1016/j.cell.2016.05.082 (2016).

    Article 
    CAS 

    Google Scholar
     

  • Lancaster, M. A. & Huch, M. Disease modelling in human organoids. Dis. Model Mech. 12, dmm039347. https://doi.org/10.1242/dmm.039347 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Huang, Y. et al. Air pollution, genetic factors, and the risk of lung cancer: A prospective study in the UK biobank. Am. J. Respir. Crit. Care Med. 204, 817–825. https://doi.org/10.1164/rccm.202011-4063OC (2021).

    Article 
    CAS 

    Google Scholar
     

  • Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188-204.e22. https://doi.org/10.1016/j.cell.2019.11.036 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Said, M. A., Verweij, N. & van der Harst, P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank study. JAMA Cardiol. 3, 693–702. https://doi.org/10.1001/jamacardio.2018.1717 (2018).

    Article 

    Google Scholar
     

  • Muller, D. C., Johansson, M. & Brennan, P. Lung cancer risk prediction model incorporating lung function: Development and validation in the UK Biobank prospective cohort study. J. Clin. Oncol. 35, 861–869. https://doi.org/10.1200/JCO.2016.69.2467 (2017).

    Article 

    Google Scholar
     

  • Wang, Q. L., Ness-Jensen, E., Santoni, G., Xie, S. H. & Lagergren, J. Development and validation of a risk prediction model for esophageal squamous cell carcinoma using cohort studies. Am. J. Gastroenterol. 116, 683–691. https://doi.org/10.14309/ajg.0000000000001094 (2021).

    Article 

    Google Scholar
     

  • Takahashi, Y. et al. A refined culture system for human induced pluripotent stem cell-derived intestinal epithelial organoids. Stem Cell Rep. 10, 314–328. https://doi.org/10.1016/j.stemcr.2017.11.004 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Noguchi, T. K. et al. Generation of stomach tissue from mouse embryonic stem cells. Nat. Cell Biol. 17, 984–993. https://doi.org/10.1038/ncb3200 (2015).

    Article 
    CAS 

    Google Scholar
     

  • McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920–1928. https://doi.org/10.1038/nprot.2011.410 (2011).

    Article 
    CAS 

    Google Scholar
     

  • Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265. https://doi.org/10.1038/nature07935 (2009).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945. https://doi.org/10.1016/j.cell.2015.03.053 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920–926. https://doi.org/10.1126/science.aao2774 (2018).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827–838. https://doi.org/10.1016/j.stem.2016.04.003 (2016).

    Article 
    CAS 

    Google Scholar
     

  • Kraiczy, J. et al. DNA methylation defines regional identity of human intestinal epithelial organoids and undergoes dynamic changes during development. Gut 68, 49–61. https://doi.org/10.1136/gutjnl-2017-314817 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Zachos, N. C. et al. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291, 3759–3766. https://doi.org/10.1074/jbc.R114.635995 (2016).

    Article 
    CAS 

    Google Scholar
     

  • Saksena, S. Nonpharmacologic therapy for tachyarrhythmias: The tower of Babel revisited?. Pacing Clin. Electrophysiol. 11, 93–97. https://doi.org/10.1111/j.1540-8159.1988.tb03932.x (1988).

    Article 
    CAS 

    Google Scholar
     

  • Xu, R., Zhou, X., Wang, S. & Trinkle, C. Tumor organoid models in precision medicine and investigating cancer-stromal interactions. Pharmacol. Ther. 218, 107668. https://doi.org/10.1016/j.pharmthera.2020.107668 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: Model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571–584. https://doi.org/10.1038/s41580-020-0259-3 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Dekkers, J. F. et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci. Transl. Med. 8, 344ra84. https://doi.org/10.1126/scitranslmed.aad8278 (2016).

    Article 
    CAS 

    Google Scholar
     

  • Sugimoto, S. et al. Reconstruction of the human colon epithelium in vivo. Cell Stem Cell. 22, 171-176.e5. https://doi.org/10.1016/j.stem.2017.11.012 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Driehuis, E., Kretzschmar, K. & Clevers, H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat. Protoc. 15, 3380–3409. https://doi.org/10.1038/s41596-020-0379-4 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Maenhoudt, N. et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Rep. 14, 717–729. https://doi.org/10.1016/j.stemcr.2020.03.004 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Lu, Z., Nie, B., Zhai, W. & Hu, Z. Delineating the longitudinal tumor evolution using organoid models. J. Genet. Genom. 48, 560–570. https://doi.org/10.1016/j.jgg.2021.06.010 (2021).

    Article 

    Google Scholar
     

  • Wang, Z. et al. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun. 42, 245–265. https://doi.org/10.1002/cac2.12274 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Rao, S., Hossain, T. & Mahmoudi, T. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Lett. 506, 35–44. https://doi.org/10.1016/j.canlet.2021.02.024 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Yoshida, S., Miwa, H., Kawachi, T., Kume, S. & Takahashi, K. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing. Sci. Rep. 10, 5989. https://doi.org/10.1038/s41598-020-63151-z (2020).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • d’Aldebert, E. et al. Characterization of human colon organoids from inflammatory bowel disease patients. Front. Cell Dev. Biol. 8, 363. https://doi.org/10.3389/fcell.2020.00363 (2020).

    Article 

    Google Scholar
     

  • Min, S., Kim, S. & Cho, S. W. Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches. Exp. Mol. Med. 52, 227–237. https://doi.org/10.1038/s12276-020-0386-0 (2020).

    Article 
    CAS 

    Google Scholar
     

  • den Hertog, J. & de Laat, S. W. Hubrecht Institute Centennial: From embryos to stem cells. Dev. Biol. 428, 261–263. https://doi.org/10.1016/j.ydbio.2017.02.004 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Rabouille, C. & Deschamps, J. On the shoulders of Hubrecht: From embryos to stem cells. Dev. Biol. 428, 264–272. https://doi.org/10.1016/j.ydbio.2016.10.005 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Reddelle, A. K. Innovation in brain tumor treatment: A nurse perspective. Cureus 13, e20037. https://doi.org/10.7759/cureus.20037 (2021).

    Article 

    Google Scholar
     

  • Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 20, 1–86. https://doi.org/10.1093/neuonc/noy131 (2018).

    Article 

    Google Scholar
     

  • Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C. & Barnholtz-Sloan, J. S. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol. 23, 1–105. https://doi.org/10.1093/neuonc/noab200 (2018).

    Article 

    Google Scholar
     

  • Yang, P. et al. Management and survival rates in patients with glioma in China (2004–2010): A retrospective study from a single-institution. J. Neurooncol. 113, 259–266. https://doi.org/10.1007/s11060-013-1103-9 (2013).

    Article 
    CAS 

    Google Scholar
     

  • Helguera, G. et al. Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry. J. Immunol. Methods 368, 54–63. https://doi.org/10.1016/j.jim.2011.03.003 (2011).

    Article 
    CAS 

    Google Scholar
     

  • Darmanis, S. et al. Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 21, 1399–1410. https://doi.org/10.1016/j.celrep.2017.10.030 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835-849.e21. https://doi.org/10.1016/j.cell.2019.06.024 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401. https://doi.org/10.1126/science.1254257 (2014).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Mandel, J. J. et al. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 20, 113–122. https://doi.org/10.1093/neuonc/nox144 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Abdullah, K. G. et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro Oncol. 24, 612–623. https://doi.org/10.1093/neuonc/noab273 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Si, Y. F. et al. A study on the value of narrow-band imaging (NBI) for the general investigation of a high-risk population of nasopharyngeal carcinoma (NPC). World J. Surg. Oncol. 16, 126. https://doi.org/10.1186/s12957-018-1423-5 (2018).

    Article 

    Google Scholar
     

  • Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394, 64–80. https://doi.org/10.1016/S0140-6736(19)30956-0 (2019).

    Article 

    Google Scholar
     

  • Thamboo, A., Patel, V. S. & Hwang, P. H. 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. J. Otolaryngol. Head Neck Surg. 50, 12. https://doi.org/10.1186/s40463-020-00482-x (2021).

    Article 

    Google Scholar
     

  • Chen, W. et al. Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma. Cancer Med. 9, 1209–1219. https://doi.org/10.1002/cam4.2778 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Wang, X. W. et al. Establishment of a patient-derived organoid model and living biobank for nasopharyngeal carcinoma. Ann. Transl. Med. 10, 526. https://doi.org/10.21037/atm-22-1076 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Yan, H. H. N. et al. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles. Gut 69, 2165–2179. https://doi.org/10.1136/gutjnl-2019-320019 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17-26.e6. https://doi.org/10.1016/j.stem.2019.10.010 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Geevimaan, K. et al. Patient-derived organoid serves as a platform for personalized chemotherapy in advanced colorectal cancer patients. Front. Oncol. 12, 883437. https://doi.org/10.3389/fonc.2022.883437 (2022).

    Article 

    Google Scholar
     

  • Mo, S. et al. Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy. Adv. Sci. 9, e2204097. https://doi.org/10.1002/advs.202204097 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Laoukili, J. et al. Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. Br. J. Cancer 126, 1824–1833. https://doi.org/10.1038/s41416-022-01742-5 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Usui, T. et al. Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture. Int. J. Mol. Sci. 19, 1098. https://doi.org/10.3390/ijms19041098 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Yao, L. et al. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy. J. Chemother. https://doi.org/10.1080/1120009X.2022.2045827 (2022).

    Article 

    Google Scholar
     

  • Herpers, B. et al. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors. Nat. Cancer 3, 418–436. https://doi.org/10.1038/s43018-022-00359-0 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Yan, H. H. N. et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 23, 882-897.e11. https://doi.org/10.1016/j.stem.2018.09.016 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Schütte, M. et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat. Commun. 8, 14262. https://doi.org/10.1038/ncomms14262 (2017).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Mohammadian, M., Allah Bakeshei, K. & Mohammadian-Hafshejani, A. International epidemiology of liver cancer: Geographical distribution, secular trends and predicting the future. J. Prev. Med. Hyg. 61, E259–E289. https://doi.org/10.15167/2421-4248/jpmh2020.61.2.1244 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Nuciforo, S. et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 24, 1363–1376. https://doi.org/10.1016/j.celrep.2018.07.001 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Rawla, P., Sunkara, T. & Gaduputi, V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J. Oncol. 10, 10–27. https://doi.org/10.14740/wjon1166 (2019).

    Article 

    Google Scholar
     

  • Saad, A. M., Turk, T., Al-Husseini, M. J. & Abdel-Rahman, O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 18, 688. https://doi.org/10.1186/s12885-018-4610-4 (2018).

    Article 

    Google Scholar
     

  • Patel, N., Khorolsky, C. & Benipal, B. Incidence of pancreatic adenocarcinoma in the United States from 2001 to 2015: A United States cancer statistics analysis of 50 states. Cureus 10, e3796. https://doi.org/10.7759/cureus.3796 (2018).

    Article 

    Google Scholar
     

  • Gordon-Dseagu, V. L., Devesa, S. S., Goggins, M. & Stolzenberg-Solomon, R. Pancreatic cancer incidence trends: Evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int. J. Epidemiol. 47, 427–439. https://doi.org/10.1093/ije/dyx232 (2018).

    Article 

    Google Scholar
     

  • Wong, M. C. S. et al. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci. Rep. 7, 3165. https://doi.org/10.1038/s41598-017-02997-2 (2017).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Farrell, J. J. Prevalence, diagnosis and management of pancreatic cystic neoplasms: Current status and future directions. Gut Liver 9, 571–589. https://doi.org/10.5009/gnl15063 (2015).

    Article 

    Google Scholar
     

  • Basar, O. & Brugge, W. R. My treatment approach: Pancreatic cysts. Mayo Clin. Proc. 92, 1519–1531. https://doi.org/10.1016/j.mayocp.2017.06.017 (2017).

    Article 

    Google Scholar
     

  • Beato, F. et al. Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas. Lab. Invest. 101, 204–217. https://doi.org/10.1038/s41374-020-00494-1 (2021).

    Article 

    Google Scholar
     

  • Huang, B. et al. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms. J. Pathol. 252, 252–262. https://doi.org/10.1002/path.5515 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Hirt, C. K. et al. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment. Cell Genom. 2, 100095. https://doi.org/10.1016/j.xgen.2022.100095 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Demyan, L. et al. Pancreatic cancer patient-derived organoids can predict response to neoadjuvant chemotherapy. Ann. Surg. 276, 450–462. https://doi.org/10.1097/SLA.0000000000005558 (2022).

    Article 

    Google Scholar
     

  • Driehuis, E. et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl. Acad. Sci. U S A 116, 26580–26590. https://doi.org/10.1073/pnas.1911273116 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Vaes, R. D. W. et al. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. J. Cachexia Sarcopenia Muscle 11, 1509–1524. https://doi.org/10.1002/jcsm.12627 (2020).

    Article 

    Google Scholar
     

  • Kawasaki, K. et al. An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell 183, 1420-1435.e21. https://doi.org/10.1016/j.cell.2020.10.023 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Bray, F. et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424. https://doi.org/10.3322/caac.21492(2018) (2018).

    Article 

    Google Scholar
     

  • Sun, X., Bao, J. & Shao, Y. Mathematical modeling of therapy-induced cancer drug resistance: Connecting cancer mechanisms to population survival rates. Sci. Rep. 6, 22498. https://doi.org/10.1038/srep22498 (2016).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Kaur, P., Garg, T., Rath, G., Murthy, R. S. & Goyal, A. K. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 23, 727–738. https://doi.org/10.3109/10717544.2014.935530 (2016).

    Article 
    CAS 

    Google Scholar
     

  • Zhang, Z. et al. Establishment of patient-derived tumor spheroids for non-small cell lung cancer. PLoS ONE 13, e0194016. https://doi.org/10.1371/journal.pone.0194016 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Kim, S. Y. et al. Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clin. Cancer Res. 27, 4397–4409. https://doi.org/10.1158/1078-0432.CCR-20-5026 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Li, Y. F. et al. Patient-derived organoids of non-small cells lung cancer and their application for drug screening. Neoplasma 67, 430–437. https://doi.org/10.4149/neo_2020_190417N346 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310. https://doi.org/10.1038/s41467-020-15155-6 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796–2810. https://doi.org/10.1016/S0140-6736(16)30512-8 (2016).

    Article 

    Google Scholar
     

  • Knowles, M. A. & Hurst, C. D. Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity. Nat. Rev. Cancer 15, 25–41. https://doi.org/10.1038/nrc3817 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Lerner, S. P. et al. Summary and recommendations from the national cancer institute’s clinical trials planning meeting on novel therapeutics for non-muscle invasive bladder cancer. Bladder Cancer 2, 165–202. https://doi.org/10.3233/BLC-160053 (2016).

    Article 

    Google Scholar
     

  • Lee, S. H. et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173, 515-528.e17. https://doi.org/10.1016/j.cell.2018.03.017 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Weber, C. A biobank for bladder cancer. Nat. Cell Biol. 20, 634. https://doi.org/10.1038/s41556-018-0114-3 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Mullenders, J. et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc. Natl. Acad. Sci. U S A 116, 4567–4574. https://doi.org/10.1073/pnas.1803595116 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Elbadawy, M. et al. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 110, 2806–2821. https://doi.org/10.1111/cas.14118 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Elbadawy, M. et al. Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method. Biomed. Pharmacother. 151, 113105. https://doi.org/10.1016/j.biopha.2022.113105 (2022).

    Article 

    Google Scholar
     

  • Nuhn, P. et al. Update on systemic prostate cancer therapies: Management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur. Urol. 75, 88–99. https://doi.org/10.1016/j.eururo.2018.03.028 (2019).

    Article 

    Google Scholar
     

  • Beshiri, M. L. et al. A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening. Clin. Cancer Res. 24, 4332–4345. https://doi.org/10.1158/1078-0432.CCR-18-0409 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Lõhmussaar, K. et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell 28, 1380-1396.e6. https://doi.org/10.1016/j.stem.2021.03.012 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47. https://doi.org/10.1038/nature14415 (2015).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Matano, M. et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21, 256–262. https://doi.org/10.1038/nm.3802 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386. https://doi.org/10.1002/ijc.29210 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Nelson, L. et al. A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity. Nat. Commun. 11, 822. https://doi.org/10.1038/s41467-020-14551-2 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • DeSantis, C. E. et al. Breast cancer statistics, 2019. CA Cancer J. Clin. 69, 438–451. https://doi.org/10.3322/caac.21583 (2019).

    Article 

    Google Scholar
     

  • Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54. https://doi.org/10.1038/nature17676 (2016).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Dekkers, J. F. et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat. Protoc. 16, 1936–1965. https://doi.org/10.1038/s41596-020-00474-1 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373-386.e10. https://doi.org/10.1016/j.cell.2017.11.010 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Mazzucchelli, S. et al. Establishment and morphological characterization of patient-derived organoids from breast cancer. Biol. Proced. Online 21, 12. https://doi.org/10.1186/s12575-019-0099-8 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Shu, D. et al. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. Ann. Med. 54, 2581–2597. https://doi.org/10.1080/07853890.2022.2122550 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Kim, J. et al. Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response. Mol. Cancer Res. 18, 253–263. https://doi.org/10.1158/1541-7786.MCR-19-0453 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Bhatia, S. et al. Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics. Cancer Res. 82, 1174–1192. https://doi.org/10.1158/0008-5472.CAN-21-2807 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Francies, H. E., Barthorpe, A., McLaren-Douglas, A., Barendt, W. J. & Garnett, M. J. Drug sensitivity assays of human cancer organoid cultures. Methods Mol. Biol. 1576, 339–351. https://doi.org/10.1007/7651_2016_10 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Liu, H. D., Xia, B. R., Jin, M. Z. & Lou, G. Organoid of ovarian cancer: Genomic analysis and drug screening. Clin. Transl. Oncol. 22, 1240–1251. https://doi.org/10.1007/s12094-019-02276-8 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Pasch, C. A. et al. Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clin. Cancer Res. 25, 5376–5387. https://doi.org/10.1158/1078-0432.CCR-18-3590 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Kong, J. et al. Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients. Nat. Commun. 11, 5485. https://doi.org/10.1038/s41467-020-19313-8 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25(10), 1607–1614. https://doi.org/10.1038/s41591-019-0584-2 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Chew, N. J. et al. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models. Breast Cancer Res. 23, 82. https://doi.org/10.1186/s13058-021-01461-4 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Ding, S. et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell 29, 905-917.e6. https://doi.org/10.1016/j.stem.2022.04.006 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Yu, C. et al. ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. Nat. Commun. 13, 3501. https://doi.org/10.1038/s41467-022-31197-4 (2022).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Martinelli, I. et al. Brain and retinal organoids for disease modeling: The importance of in vitro blood-brain and retinal barriers studies. Cells 11, 1120. https://doi.org/10.3390/cells11071120 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Jabs, J. et al. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Mol. Syst. Biol. 13, 955. https://doi.org/10.15252/msb.20177697 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Park, S. E., Georgescu, A. & Huh, D. Organoids-on-a-chip. Science 364, 960–965. https://doi.org/10.1126/science.aaw7894 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Michl, J., Park, K. C. & Swietach, P. Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun. Biol. 2, 144. https://doi.org/10.1038/s42003-019-0393-7 (2019).

    Article 

    Google Scholar
     

  • Gonzalez-Exposito, R. et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J. Immunother. Cancer 7, 101. https://doi.org/10.1186/s40425-019-0575-3 (2019).

    Article 

    Google Scholar
     

  • Zhao, H., Jiang, E. & Shang, Z. 3D co-culture of cancer-associated fibroblast with oral cancer organoids. J. Dent. Res. 100, 201–208. https://doi.org/10.1177/0022034520956614 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Staab, J. F., Lemme-Dumit, J. M., Latanich, R., Pasetti, M. F. & Zachos, N. C. Co-culture system of human enteroids/colonoids with innate immune cells. Curr. Protoc. Immunol. 131, e113. https://doi.org/10.1002/cpim.113 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Morgan, K. M., Riedlinger, G. M., Rosenfeld, J., Ganesan, S. & Pine, S. R. Patient-derived xenograft models of non-small cell lung cancer and their potential utility in personalized medicine. Front. Oncol. 7, 2. https://doi.org/10.3389/fonc.2017.00002 (2017).

    Article 

    Google Scholar
     

  • Luo, X. et al. Hydrogel-based colorectal cancer organoid co-culture models. Acta Biomater. 132, 461–472. https://doi.org/10.1016/j.actbio.2020.12.037 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32, 773–785. https://doi.org/10.1038/nbt.2958 (2014).

    Article 
    CAS 

    Google Scholar
     

  • Xu, F. et al. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol. J. 6, 204–212. https://doi.org/10.1002/biot.201000340 (2011).

    Article 
    CAS 

    Google Scholar
     

  • Skardal, A. et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci. Rep. 7(1), 8837. https://doi.org/10.1038/s41598-017-08879-x (2017).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Buqué, A. & Galluzzi, L. Modeling tumor immunology and immunotherapy in mice. Trends Cancer 4, 599–601. https://doi.org/10.1016/j.trecan.2018.07.003 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Li, Q. et al. Developing covalent protein drugs via proximity-enabled reactive therapeutics. Cell 182, 85-97.e16. https://doi.org/10.1016/j.cell.2020.05.028 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Curvello, R., Alves, D., Abud, H. E. & Garnier, G. A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids. Mater. Sci. Eng. C 124, 112051. https://doi.org/10.1016/j.msec.2021.112051 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Nagle, P. W., Plukker, J. T. M., Muijs, C. T., van Luijk, P. & Coppes, R. P. Patient-derived tumor organoids for prediction of cancer treatment response. Semin. Cancer Biol. 53, 258–264. https://doi.org/10.1016/j.semcancer.2018.06.005 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Hirokawa, Y. et al. Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine. Commun. Biol. 4, 1067. https://doi.org/10.1038/s42003-021-02607-y (2021).

    Article 
    CAS 

    Google Scholar
     

  • Fujii, M. et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23, 787-793.e6. https://doi.org/10.1016/j.stem.2018.11.016 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Hoffmann, K. et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment. EMBO J. 39, e104013. https://doi.org/10.15252/embj.2019104013 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Utta, D., Heo, I. & Clevers, H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol. Med. 23, 393–410. https://doi.org/10.1016/j.molmed.2017.02.007 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Lensink, M. A. et al. Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking. J. Cyst Fibros. 20, 443–451. https://doi.org/10.1016/j.jcf.2020.11.015 (2021).

    Article 

    Google Scholar
     

  • Lensink, M. A., Boers, S. N., Gulmans, V. A., Jongsma, K. R. & Bredenoord, A. L. Mini-gut feelings: Perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking. Pers. Med. 18, 241–254. https://doi.org/10.2217/pme-2020-01 (2021).

    Article 

    Google Scholar
     

  • COTA Joins Multistakeholder Clinical Research Data Sharing Alliance

    The serious-earth oncology information and analytics organization COTA currently declared its partnership with the Clinical Investigation Facts Sharing Alliance (CRDSA), a non-income, multi-stakeholder consortium that aims to accelerate development in most cancers remedy progress by way of improved knowledge sharing.

    CRDSA was proven in 2021 and contains biopharmaceutical organizations, knowledge sharing platforms, educational institutions, and provider and technological innovation partners whose widespread goal is to facilitate medical knowledge sharing. Broadening accessibility to deidentified individual information can assistance make improvements to the over-all analysis system and make cancer drug growth much more effective, in accordance to a assertion from COTA.

    COTA will be element of the CRDSA steering committee and the Impressive Demo Design and style Functioning Group, which aims to establish novel techniques to demo design that involve information reuse, as nicely as travel policy improvements that make modern scientific demo execution feasible.

    “Responsible, ethical, and compliant data sharing has the possible to revolutionize health care. Nonetheless, we are however in the early levels when it comes to details standardization, regulatory advice, and governing policies,” C.K. Wang, MD, chief health care officer at COTA, explained in a statement. “We are pleased to perform with cross-marketplace teams like CRDSA as they construct have faith in and demonstrate the price of facts sharing for all stakeholder teams, notably people.”

    The 1st Modern Trial Style and design Functioning Team challenge involving COTA, the Supplemental Controls Demonstration Venture, will emphasis on non–small-mobile lung cancer investigate and drug advancement. The job aims to tackle gaps in assistance and generate requirements that can advise updated health and fitness authority assistance on the use of client-amount knowledge from scientific trials and the genuine earth.

    The undertaking builds on Food and drug administration function by CRDSA members and will tackle “data provenance, review and matter selection methodologies, and multi-modal investigation checking out the synergistic reuse of medical demo info and [real-world data],” according to the official task description.

    CRDSA has currently printed multiple direction and framework paperwork intended to support stakeholders as they examine technologies that boost info sharing although guaranteeing and even more improving affected person privacy. These plans are in line with people of COTA, which was founded with a mission of organizing beforehand inaccessible or fragmented real-entire world details to ahead cancer study and treatment.

    “Industry and regulators are more and more wanting to leverage the totality of evidence produced from authentic-earth and clinical demo knowledge to progress the drug progress and approval procedure,” said Aaron Mann, CEO of CRDSA. “As we acquire these capabilities, regulators want help, steering, and multi-stakeholder feedback to build greatest procedures and suggestions for working with these numerous multi-modal datasets to guidance drug approvals, publish-market surveillance, and other use instances.”

    UK clinical research could be ‘diminished’

    The Household of Lords’ committee wrote to​ the Minister of State for Health and Social Treatment, Steve Barclay, with the conclusions it drew from its inquiry, which provided a variety of locations for ‘urgent action’.

    The letter put into context that inspite of the UK’s ‘current economic situation’ and the ‘significant NHS backlog’, the net advantage of clinical exploration can mitigate workforce worries and enhance patient outcomes. However, the inquiry experienced observed that the scientific research ecosystem in the NHS is on a ‘dangerous precipice’ and with out action, the nation would reduce out on these types of benefits.

    Chair of the Science and Know-how Committee, Julia King, reported: “Through the course of our inquiry we read alarming reports about the declining point out of clinical analysis in the NHS. ​

    “There is a ‘leaky pipeline’ for marketing consultant medical lecturers who usually travel professional medical breakthroughs into frontline client care. If problems in shell out and pension inequality are not tackled, we are in risk of permanently eroding the medical research workforce and it is patients who will experience.​”

    Further, King noted her problems that if measures are not taken by the Uk governing administration then the country’s scientific research capacity could be ‘permanently diminished’.

    As a response to this predicament, the inquiry advised several potential tips, which bundled improved pay back to tackle inequalities that disincentivise clinical academia as a profession pathway, and to get rid of steps that inspire early retirement for NHS consultants.